Dana Cucerov

Dana Cucerov (Mantaluta) is an experienced finance professional with a robust background in the pharmaceutical and biotechnology sectors. Currently serving as the Head of Finance for the US Rx Business Unit at Galderma since March 2024, Dana has held senior roles at Deciphera Pharmaceuticals, including Senior Director of Commercial Finance and Finance Strategy, as well as Director positions. Prior experience includes leadership roles in financial planning and analysis at Ohana Biosciences and strategic corporate finance at Biogen. Dana has demonstrated expertise in revenue forecasting and financial management through positions at Vista and The Cumberland Group. Educational credentials include an MBA in Finance from Boston College Carroll School of Management and a B.A. in Economics and Political Science from The University of the South.